Advocacy

The National Association of Specialty Pharmacy has submitted its comments to the Centers for Medicare and Medicaid Services in response to the agency’s proposed Medicare Part D rule reform.

The National Association of Chain Drug Stores team members who have been promoted have a combined 40 years of NACDS service and 80 total years of experience in NACDS’ priority issues, the organization said.

A total of 256 Project Health events are slated to take place in 2019.

NACDS highlighted the role of pharmacists in its recommendations for the Department of Health and Human Services' Healthy People 2030 initiative.

NCPA's efforts to build support for parts of the Center for Medicare and Medicaid Services' drug pricing rule involving DIR fees has drawn wide support among pharmacists and stakeholders.

The Center for Medicare and Medicaid Services’ proposed changes to protected drug classes would jeopardize coverage for beneficiaries, according to PhRMA’s comments on the agency’s proposed rule.

NACDS is making the case that DIR fee reform is necessary in its comments to the Centers for Medicare and Medicaid Services, which recently issued a proposed rule focused on reducing patient out-of-pocket costs.

With the addition of the two members, the Pharmaceutical Research and Manufacturers of America's membership now comprises the top 20 biopharmaceutical companies.